piracetam has been researched along with Progeria in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Progeria: An abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature graying; hair loss; hearing loss (DEAFNESS); cataracts (CATARACT); ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorn, M | 1 |
1 trial available for piracetam and Progeria
| Article | Year |
|---|---|
[Piracetam in premature biological aging. Double-blind study after preselection by drugs].
Topics: Aged; Aging; Double-Blind Method; Humans; Hypoxia, Brain; Piracetam; Placebos; Progeria; Pyrrolidino | 1978 |